A case of primary pulmonary plasmacytoma presenting as endobronchial mass

Soon Yong Suh, Gang Jee Ko, Chung Ho Kim, Youn Ho Kim, Sung Yong Lee, Sang Yeub Lee, Je Hyeong Kim, Chol Shin, Jae Jeong Shim, Kwang Ho In, Kyung Ho Kang, Se Hwa Yoo

Research output: Contribution to journalArticle

Abstract

Extramedullary plasmacytoma(EMP) comprises 5% of all plasma cell neoplasms and commonly occurs in the upper airway or digestive tract. However, it rarely develops in the lungs. We present a case of primary pulmonary plasmacyotma in a 45 year old man, who presented as an endobronchial mass with a pleural effusion, but without evidence of multiple myeloma. The treatment options for EMP include surgery, surgery and radiotherapy, surgery and chemotherapy or chemotherapy alone. Surgery and radiation therapy appeared to be equally effective forms of treatment. The local recurrence rate was reported to be 30%, with 48% progressing to multiple myeloma, and median survival was reported to be 63-101 months. Our patient was initially treated with melphalan and prednisolone. However the disease progressed, and radiotherapy was combined with chemotherapy. In addition, the chemotherapy regimen was also changed to thalidomide and dexamethasone. The patient did not respond to this treatment regimen and finally died.

Original languageEnglish
Pages (from-to)664-669
Number of pages6
JournalTuberculosis and Respiratory Diseases
Volume56
Issue number6
Publication statusPublished - 2004 Jun 1

Fingerprint

Plasmacytoma
Drug Therapy
Lung
Radiotherapy
Multiple Myeloma
Plasma Cell Neoplasms
Melphalan
Thalidomide
Pleural Effusion
Prednisolone
Dexamethasone
Gastrointestinal Tract
Therapeutics
Recurrence
Survival

Keywords

  • Endobronchial mass
  • Extramedullary plasmacytoma
  • Pulmonary plasmacytoma

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

A case of primary pulmonary plasmacytoma presenting as endobronchial mass. / Suh, Soon Yong; Ko, Gang Jee; Kim, Chung Ho; Kim, Youn Ho; Lee, Sung Yong; Lee, Sang Yeub; Kim, Je Hyeong; Shin, Chol; Shim, Jae Jeong; In, Kwang Ho; Kang, Kyung Ho; Yoo, Se Hwa.

In: Tuberculosis and Respiratory Diseases, Vol. 56, No. 6, 01.06.2004, p. 664-669.

Research output: Contribution to journalArticle

@article{c91303626ab6479d8ea498d83ec6a4a5,
title = "A case of primary pulmonary plasmacytoma presenting as endobronchial mass",
abstract = "Extramedullary plasmacytoma(EMP) comprises 5{\%} of all plasma cell neoplasms and commonly occurs in the upper airway or digestive tract. However, it rarely develops in the lungs. We present a case of primary pulmonary plasmacyotma in a 45 year old man, who presented as an endobronchial mass with a pleural effusion, but without evidence of multiple myeloma. The treatment options for EMP include surgery, surgery and radiotherapy, surgery and chemotherapy or chemotherapy alone. Surgery and radiation therapy appeared to be equally effective forms of treatment. The local recurrence rate was reported to be 30{\%}, with 48{\%} progressing to multiple myeloma, and median survival was reported to be 63-101 months. Our patient was initially treated with melphalan and prednisolone. However the disease progressed, and radiotherapy was combined with chemotherapy. In addition, the chemotherapy regimen was also changed to thalidomide and dexamethasone. The patient did not respond to this treatment regimen and finally died.",
keywords = "Endobronchial mass, Extramedullary plasmacytoma, Pulmonary plasmacytoma",
author = "Suh, {Soon Yong} and Ko, {Gang Jee} and Kim, {Chung Ho} and Kim, {Youn Ho} and Lee, {Sung Yong} and Lee, {Sang Yeub} and Kim, {Je Hyeong} and Chol Shin and Shim, {Jae Jeong} and In, {Kwang Ho} and Kang, {Kyung Ho} and Yoo, {Se Hwa}",
year = "2004",
month = "6",
day = "1",
language = "English",
volume = "56",
pages = "664--669",
journal = "Tuberculosis and Respiratory Diseases",
issn = "1738-3536",
publisher = "The Korean Academy of Tuberculosis and Respiratory Diseases",
number = "6",

}

TY - JOUR

T1 - A case of primary pulmonary plasmacytoma presenting as endobronchial mass

AU - Suh, Soon Yong

AU - Ko, Gang Jee

AU - Kim, Chung Ho

AU - Kim, Youn Ho

AU - Lee, Sung Yong

AU - Lee, Sang Yeub

AU - Kim, Je Hyeong

AU - Shin, Chol

AU - Shim, Jae Jeong

AU - In, Kwang Ho

AU - Kang, Kyung Ho

AU - Yoo, Se Hwa

PY - 2004/6/1

Y1 - 2004/6/1

N2 - Extramedullary plasmacytoma(EMP) comprises 5% of all plasma cell neoplasms and commonly occurs in the upper airway or digestive tract. However, it rarely develops in the lungs. We present a case of primary pulmonary plasmacyotma in a 45 year old man, who presented as an endobronchial mass with a pleural effusion, but without evidence of multiple myeloma. The treatment options for EMP include surgery, surgery and radiotherapy, surgery and chemotherapy or chemotherapy alone. Surgery and radiation therapy appeared to be equally effective forms of treatment. The local recurrence rate was reported to be 30%, with 48% progressing to multiple myeloma, and median survival was reported to be 63-101 months. Our patient was initially treated with melphalan and prednisolone. However the disease progressed, and radiotherapy was combined with chemotherapy. In addition, the chemotherapy regimen was also changed to thalidomide and dexamethasone. The patient did not respond to this treatment regimen and finally died.

AB - Extramedullary plasmacytoma(EMP) comprises 5% of all plasma cell neoplasms and commonly occurs in the upper airway or digestive tract. However, it rarely develops in the lungs. We present a case of primary pulmonary plasmacyotma in a 45 year old man, who presented as an endobronchial mass with a pleural effusion, but without evidence of multiple myeloma. The treatment options for EMP include surgery, surgery and radiotherapy, surgery and chemotherapy or chemotherapy alone. Surgery and radiation therapy appeared to be equally effective forms of treatment. The local recurrence rate was reported to be 30%, with 48% progressing to multiple myeloma, and median survival was reported to be 63-101 months. Our patient was initially treated with melphalan and prednisolone. However the disease progressed, and radiotherapy was combined with chemotherapy. In addition, the chemotherapy regimen was also changed to thalidomide and dexamethasone. The patient did not respond to this treatment regimen and finally died.

KW - Endobronchial mass

KW - Extramedullary plasmacytoma

KW - Pulmonary plasmacytoma

UR - http://www.scopus.com/inward/record.url?scp=4444248792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444248792&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:4444248792

VL - 56

SP - 664

EP - 669

JO - Tuberculosis and Respiratory Diseases

JF - Tuberculosis and Respiratory Diseases

SN - 1738-3536

IS - 6

ER -